"Global Personalized Medicine Market Overview:
Global Personalized Medicine Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Personalized Medicine Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Personalized Medicine involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Personalized Medicine Market:
The Personalized Medicine Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Personalized Medicine Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Personalized Medicine Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Personalized Medicine market has been segmented into:
Therapeutics and Diagnostics
By Application, Personalized Medicine market has been segmented into:
Oncology
Immunology
Neurology
Cardiology
Autoimmune Diseases
and Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Personalized Medicine market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Personalized Medicine market.
Top Key Players Covered in Personalized Medicine market are:
Precision Biologics
Danaher Corporation
Abbott
Illuminainc.
Exact Sciences Corporation
ASURAGENinc.
Exagen Inc.
Genentechinc.
Berg Health
Omada Health
Natera
Invitae
Myriad Genetics
Celcuity
InsightRX
Axial3D
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Personalized Medicine Market by Type
4.1 Personalized Medicine Market Snapshot and Growth Engine
4.2 Personalized Medicine Market Overview
4.3 Therapeutics and Diagnostics
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Therapeutics and Diagnostics: Geographic Segmentation Analysis
Chapter 5: Personalized Medicine Market by Application
5.1 Personalized Medicine Market Snapshot and Growth Engine
5.2 Personalized Medicine Market Overview
5.3 Oncology
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Oncology: Geographic Segmentation Analysis
5.4 Immunology
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Immunology: Geographic Segmentation Analysis
5.5 Neurology
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Neurology: Geographic Segmentation Analysis
5.6 Cardiology
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Cardiology: Geographic Segmentation Analysis
5.7 Autoimmune Diseases
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Autoimmune Diseases: Geographic Segmentation Analysis
5.8 and Others
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 and Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Personalized Medicine Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 PRECISION BIOLOGICS
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 DANAHER CORPORATION
6.4 ABBOTT
6.5 ILLUMINAINC.
6.6 EXACT SCIENCES CORPORATION
6.7 ASURAGENINC.
6.8 EXAGEN INC.
6.9 GENENTECHINC.
6.10 BERG HEALTH
6.11 OMADA HEALTH
6.12 NATERA
6.13 INVITAE
6.14 MYRIAD GENETICS
6.15 CELCUITY
6.16 INSIGHTRX
6.17 AND AXIAL3D
Chapter 7: Global Personalized Medicine Market By Region
7.1 Overview
7.2. North America Personalized Medicine Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Therapeutics and Diagnostics
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Oncology
7.2.5.2 Immunology
7.2.5.3 Neurology
7.2.5.4 Cardiology
7.2.5.5 Autoimmune Diseases
7.2.5.6 and Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Personalized Medicine Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Therapeutics and Diagnostics
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Oncology
7.3.5.2 Immunology
7.3.5.3 Neurology
7.3.5.4 Cardiology
7.3.5.5 Autoimmune Diseases
7.3.5.6 and Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Personalized Medicine Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Therapeutics and Diagnostics
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Oncology
7.4.5.2 Immunology
7.4.5.3 Neurology
7.4.5.4 Cardiology
7.4.5.5 Autoimmune Diseases
7.4.5.6 and Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Personalized Medicine Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Therapeutics and Diagnostics
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Oncology
7.5.5.2 Immunology
7.5.5.3 Neurology
7.5.5.4 Cardiology
7.5.5.5 Autoimmune Diseases
7.5.5.6 and Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Personalized Medicine Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Therapeutics and Diagnostics
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Oncology
7.6.5.2 Immunology
7.6.5.3 Neurology
7.6.5.4 Cardiology
7.6.5.5 Autoimmune Diseases
7.6.5.6 and Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Personalized Medicine Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Therapeutics and Diagnostics
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Oncology
7.7.5.2 Immunology
7.7.5.3 Neurology
7.7.5.4 Cardiology
7.7.5.5 Autoimmune Diseases
7.7.5.6 and Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Personalized Medicine Scope:
|
Report Data
|
Personalized Medicine Market
|
|
Personalized Medicine Market Size in 2025
|
USD XX million
|
|
Personalized Medicine CAGR 2025 - 2032
|
XX%
|
|
Personalized Medicine Base Year
|
2024
|
|
Personalized Medicine Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Precision Biologics, Danaher Corporation, Abbott, Illuminainc., Exact Sciences Corporation, ASURAGENinc., Exagen Inc., Genentechinc., Berg Health, Omada Health, Natera, Invitae, Myriad Genetics, Celcuity, InsightRX, and Axial3D.
|
|
Key Segments
|
By Type
Therapeutics and Diagnostics
By Applications
Oncology
Immunology
Neurology
Cardiology
Autoimmune Diseases
and Others
|
